[go: up one dir, main page]

FI912914A0 - Ws622a mono- eller di-sulfat, foerfarande foer dess framstaellning och dess anvaendning. - Google Patents

Ws622a mono- eller di-sulfat, foerfarande foer dess framstaellning och dess anvaendning.

Info

Publication number
FI912914A0
FI912914A0 FI912914A FI912914A FI912914A0 FI 912914 A0 FI912914 A0 FI 912914A0 FI 912914 A FI912914 A FI 912914A FI 912914 A FI912914 A FI 912914A FI 912914 A0 FI912914 A0 FI 912914A0
Authority
FI
Finland
Prior art keywords
dess
mono
ws622a
sulfat
eller
Prior art date
Application number
FI912914A
Other languages
English (en)
Other versions
FI106554B (fi
FI912914A (fi
Inventor
Shigehiro Takase
Hiroshi Hatanaka
Masami Ezaki
Eisaku Tsujii
Masanori Okamoto
Nobuharu Shigematsu
Masakuni Okuhara
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI912914A0 publication Critical patent/FI912914A0/fi
Publication of FI912914A publication Critical patent/FI912914A/fi
Application granted granted Critical
Publication of FI106554B publication Critical patent/FI106554B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2/00Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
FI912914A 1990-06-29 1991-06-17 Menetelmä terapeuttisesti käyttökelpoisten WS7622A-mono- tai disulfaatin valmistamiseksi FI106554B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9014546 1990-06-29
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Publications (3)

Publication Number Publication Date
FI912914A0 true FI912914A0 (fi) 1991-06-17
FI912914A FI912914A (fi) 1991-12-30
FI106554B FI106554B (fi) 2001-02-28

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912914A FI106554B (fi) 1990-06-29 1991-06-17 Menetelmä terapeuttisesti käyttökelpoisten WS7622A-mono- tai disulfaatin valmistamiseksi

Country Status (22)

Country Link
US (2) US5292510A (fi)
EP (1) EP0465895B1 (fi)
JP (1) JP2663763B2 (fi)
KR (1) KR100198693B1 (fi)
CN (1) CN1073115C (fi)
AT (1) ATE138074T1 (fi)
AU (1) AU640241B2 (fi)
CA (1) CA2045761C (fi)
DE (1) DE69119488T2 (fi)
DK (1) DK0465895T3 (fi)
ES (1) ES2087178T3 (fi)
FI (1) FI106554B (fi)
GB (1) GB9014546D0 (fi)
GR (1) GR3020184T3 (fi)
HU (1) HU213398B (fi)
IE (1) IE75702B1 (fi)
IL (1) IL98394A (fi)
NO (1) NO301643B1 (fi)
PH (1) PH31239A (fi)
PT (1) PT98134B (fi)
RU (1) RU2087482C1 (fi)
ZA (1) ZA914349B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE161016T1 (de) * 1991-06-18 1997-12-15 Fujisawa Pharmaceutical Co Ws7622a enthaltende prophylaktische/therapeutische zusammensetzung zur vorbeugung und behandlung von verstreuter, intravaskulärer koagulation, chronischer, infektiöser atemwegskrankheiten oder chronischer bronchitis
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
US6610748B1 (en) * 1998-02-24 2003-08-26 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心) 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
FI106554B (fi) 2001-02-28
HU912198D0 (en) 1991-12-30
IE912047A1 (en) 1992-01-01
ES2087178T3 (es) 1996-07-16
NO912561L (no) 1991-12-30
IE75702B1 (en) 1997-09-10
ZA914349B (en) 1992-03-25
GB9014546D0 (en) 1990-08-22
KR100198693B1 (ko) 1999-06-15
PH31239A (en) 1998-06-18
CN1057655A (zh) 1992-01-08
KR920000920A (ko) 1992-01-29
IL98394A0 (en) 1992-07-15
HUT58351A (en) 1992-02-28
GR3020184T3 (en) 1996-09-30
NO912561D0 (no) 1991-06-28
AU640241B2 (en) 1993-08-19
CA2045761A1 (en) 1991-12-30
PT98134B (pt) 1998-12-31
AU7939491A (en) 1992-01-09
US5292510A (en) 1994-03-08
RU2087482C1 (ru) 1997-08-20
FI912914A (fi) 1991-12-30
ATE138074T1 (de) 1996-06-15
JP2663763B2 (ja) 1997-10-15
US5364624A (en) 1994-11-15
CA2045761C (en) 1999-09-21
JPH04279600A (ja) 1992-10-05
DK0465895T3 (da) 1996-06-03
CN1073115C (zh) 2001-10-17
PT98134A (pt) 1992-06-30
DE69119488D1 (de) 1996-06-20
EP0465895A1 (en) 1992-01-15
NO301643B1 (no) 1997-11-24
HU213398B (en) 1997-06-30
IL98394A (en) 1995-03-30
EP0465895B1 (en) 1996-05-15
DE69119488T2 (de) 1996-10-02

Similar Documents

Publication Publication Date Title
ES2148254T3 (es) Peptidos antimicrobianos ciclicos y preparacion de los mismos.
KR0141913B1 (en) Anti-virus agents
DK0623021T3 (da) 4"-deoxyerythromycinderivater
FI913769A0 (fi) Nya tricykliska foereningar eller deras salter, foerfarande foer deras framstaellning och dessa innehaollande antimikrobiellt medel.
FI891581A0 (fi) Peptidderivat.
FI912914A (fi) Ws622a mono- eller di-sulfat, foerfarande foer dess framstaellning och dess anvaendning.
FI901237A0 (fi) Ws7622a-, b-, c- och d-substanser, deras derivat, foerfarande foer deras framstaellning och deras anvaendning.
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
FI890482A (fi) B-laktam-antibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel och i laekemedel.
ZA828237B (en) A vasodilator compound,process for the preparation thereof and pharmaceutical compositions therefrom
ES2090054T3 (es) Derivados polares de cefalosporina y procedimiento para su preparacion.